UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2022	$ 36	$ 251	$ (12,039)	$ 126,006	$ 114,254
Equity Balance, shares at Dec. 31, 2022	3,628
Common stock issued upon exercise of employee stock options	$ 0	21	0	0	21
Common stock issued upon exercise of employee stock options, shares	0
Stock option compensation expense	$ 0	50	0	0	50
Foreign currency translation adjustment	0	0	549	0	549
Common stock dividends	0	0	0	(1,070)	(1,070)
Net income	0	0	0	4,214	4,214
Equity Balance, value at Mar. 31, 2023	$ 36	322	(11,491)	129,150	118,018
Equity Balance, shares at Mar. 31, 2023	3,628
Equity Balance, value at Dec. 31, 2023	$ 36	593	(10,658)	138,341	128,313
Equity Balance, shares at Dec. 31, 2023	3,630
Common stock issued upon exercise of employee stock options	$ 0	96	0	0	96
Common stock issued upon exercise of employee stock options, shares	2
Stock option compensation expense	$ 0	79	0	0	79
Common stock purchased and retired	$ 0	(769)	0	(2,221)	(2,990)
Common stock purchased and retired, shares	43
Foreign currency translation adjustment	$ 0	0	(631)	0	(631)
Common stock dividends	0	0	0	(1,081)	(1,081)
Net income	0	0	0	3,956	3,956
Equity Balance, value at Mar. 31, 2024	$ 36	$ 0	$ (11,289)	$ 138,995	$ 127,742
Equity Balance, shares at Mar. 31, 2024	3,588
Stock Repurchased and Retired During Period, Shares	(43)